Houlihan Lokey Announces Pricing of Secondary Offering of HLI Class A Common Stock by Selling Stockholder
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| PacificHealth Laboratories, Inc. (NYSE: HLI) | Delayed: 131.18 -2.06 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $133.24 | 52 Week High | $26.75 | |||
| Open | $131.18 | 52 Week Low | $20.96 | |||
| Day High | $131.18 | P/E | N/A | |||
| Day Low | $131.18 | EPS | $-0.09 | |||
| Volume | 1,156 | |||||
